ArticleScientific reports2023

Circulating cf-miRNA as a more appropriate surrogate liquid biopsy marker than cfDNA for ovarian cancer.

Aoife Ward Gahlawat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.